Forecast: Sold Production of Vaccines for Veterinary Medicine in the UK

Over the past decade, the sold production of vaccines for veterinary medicine in the UK has witnessed significant fluctuation. After a dramatic surge in 2014, reaching 399.14%, there were notable fluctuations in subsequent years, with variations swinging both positively and negatively. Between 2019 and 2020, the annual growth stabilized slightly, marked by increments of 0.36% and 4.63% in respective years. By 2023, the market value stood at 10.081 million euros. The average variation per year over the last five years (2019-2023) exhibited a steady CAGR of 7.64%. Future forecasts from 2024 to 2028 predict a more modest growth with a 5-year CAGR of 2.67%, estimating an overall increase of 14.06% by 2028.

Future trends to watch for:

• Wider adoption of precision veterinary medicine.
• Increased investments in research and development of novel vaccines.
• Potential impact of regulatory changes and government policies.
• Technological advancements driving innovation in vaccine production.
• Global influences and disease outbreaks impacting demand and supply dynamics.